Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Filings indexed 414 across all filing types
Latest filing 2025-10-14 Governance Information
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Nghị quyết HĐQT về việc sửa đổi, ban hành điều lệ công ty
Governance Information Classification · 92% confidence The document is a formal filing to the securities regulator and stock exchange announcing (and attaching) a Board resolution to amend and adopt the company’s charter (Điều lệ), followed by the full text of the amended Articles of Association. It is not a financial report, dividend notice, share issuance, legal proceeding, or meeting proxy. Instead, it is governance documentation defining internal rules, board authority, shareholder rights, and corporate structure. Therefore, it falls squarely under Governance Information (CGR).
2025-10-14 Vietnamese
DBT: Nghị quyết và Biên bản kiểm phiếu bằng hình thức lấy ý kiến cổ đông bằng văn bản
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a formal “Công bố thông tin bất thường” addressed to the State Securities Commission and HOSE, disclosing: (1) the minutes of vote-counting (“Biên bản kiểm phiếu biểu quyết”) and (2) the resolution (“Nghị Quyết Đại Hội Đồng Cổ đông”) of the Company’s 2025 General Meeting of Shareholders by written ballot. It reports vote totals, valid/invalid votes, percentages, and the approved resolution. This is exactly an official declaration of shareholder voting results at a general meeting, matching the Declaration of Voting Results & Voting Rights Announcements category.
2025-10-13 Vietnamese
DBT: Nghị quyết HĐQT về việc tăng tỷ lệ sở hữu tại CTCP Ypharco Healthcare
Major Shareholding Notification Classification · 75% confidence The document is an official disclosure to the securities regulator and stock exchange of a board resolution to increase the company’s shareholding in another listed company (Ypharco Healthcare) to 89.499%, thereby crossing a major ownership threshold. This constitutes a Major Shareholding Notification rather than a financial report or dividend or management change. Therefore it best fits the MRQ category.
2025-10-09 Vietnamese
DBT: Giấy chứng nhận đăng ký doanh nghiệp thay đổi lần thứ 26
Share Issue/Capital Change Classification · 75% confidence The document is a formal notice to the stock exchange and relevant authorities announcing a change in the company’s business registration certificate driven by an increase in charter capital through the issuance of shares. It provides details of the capital before and after the change and cites issuance of shares for dividend distribution. This corresponds to the “Share Issue/Capital Change” category.
2025-10-08 Vietnamese
DBT: Thông báo nhận được Văn bản của UBCKNN về báo cáo kết quả đợt phát hành cổ phiếu để trả cổ tức
Regulatory Filings Classification · 82% confidence The document is a non-routine disclosure by Công ty Cổ phần Dược phẩm Bến Tre announcing that it has received a regulatory letter (Văn bản số 5934/UBCK-QLCB) reporting the results of a share issuance for dividend payment. There is no substantive financial statement or report attached; the company is simply publishing compliance/regulatory information. This fits the "Regulatory Filings" category (RNS) as a general regulatory announcement.
2025-10-03 Vietnamese
DBT: Nghị quyết HĐQT về việc đăng ký thay đổi Vốn điều lệ Công ty
Share Issue/Capital Change Classification · 91% confidence The document is an official disclosure (‘Công bố thông tin bất thường’) filed with the State Securities Commission and the Ho Chi Minh Stock Exchange announcing a Board resolution (‘Nghị quyết Hội đồng quản trị’) to register an increase in the company’s charter capital (vốn điều lệ) by issuing new shares to pay dividends. This is clearly a corporate action concerning share issuance and capital change. Under the classification scheme, it falls under Share Issue/Capital Change (SHA).
2025-10-03 Vietnamese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.